NKGen Biotech Inc (NKGN) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

NKGen Biotech Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of NKGen Biotech Inc is $37.41M. A total of 3.26 million shares were traded on the day, compared to an average of 3.52M shares.

In the most recent transaction, Song Paul Y. bought 76 shares of NKGN for 3.29 per share on Dec 07 ’23. After the transaction, the Chief Executive Officer now owns 171,121 company shares. In a previous transaction on Dec 06 ’23, Song Paul Y. bought 75 shares at 3.32 per share. NKGN shares that Chief Executive Officer owns now total 171,045.

Among the insiders who bought shares, Song Paul Y. acquired of 105 shares on Dec 05 ’23 at a per-share price of $3.33. This resulted in the Chief Executive Officer holding 170,969 shares of NKGN after the transaction. In another insider transaction, Graf James A bought 450 shares at $3.19 per share on Dec 04 ’23. Company shares held by the Interim CFO now total 693.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NKGN has a high of $12.88 and a low of $0.78.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NKGN’s latest balance sheet shows that the firm has $351.00k in Cash & Short Term Investments as of fiscal 2021. There were $51.97M in debt and $55.74M in liabilities at the time. Its Book Value Per Share was -$1.85, while its Total Shareholder’s Equity was -$38.05M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.

Most Popular

Related Posts